top of page
Enterprise
Home
Get Started
Book Consultation
Pricing
The Flex Difference
Flex App
Flex Certified
Safety Information
Why We Exist
FAQs
Robb Fujioka
Admin
0
Followers
0
Following
Follow
Following icon
More actions
Profile
Profile
Join date: Feb 21, 2024
Posts
(1)
Feb 23, 2024
∙
2 min
Science’s 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Disease
https://youtu.be/QnmMSMF7wO4?si=q_Z91vorvqBT1FSH Originally developed to treat type 2 diabetes nearly 20 years ago, the excitement...
18
0
Home
Get Started
Book Consultation
Pricing
The Flex Difference
Flex App
Flex Certified
Safety Information
Why We Exist
FAQs
bottom of page